[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4843 followers Created: 2025-07-14 12:02:34 UTC $CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV  XXXXX engagements  **Related Topics** [abbv](/topic/abbv) [cort](/topic/cort) [$cort](/topic/$cort) [$abbv](/topic/$abbv) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/doepke_michel/status/1944729228684976503)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke @doepke_michel on x 4843 followers
Created: 2025-07-14 12:02:34 UTC
$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV
XXXXX engagements
Related Topics abbv cort $cort $abbv stocks healthcare
/post/tweet::1944729228684976503